The hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session, on examining the federal response to the opioid crisis, October 5, 2017 United States Congress. Senate. Committee on Health, Education, Labor, and Pensions, creator text bibliography Legislative hearings. dcu 2019 monographic eng 1 online resource (iv, 99 pages). Access ID (govinfo): CHRG-115shrg27121. CRDP Program record. Hearing witnesses: Statement of Elinore F. McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration, Rockville, MD; Statement of Debra Houry, M.D., MPH, Director, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA; Statement of Francis Collins, M.D., Ph.D., Director, National Institutes of Health, Bethesda, MD; Statement of Scott Gottlieb, M.D., Commissioner, Food and Drug Administration, Silver Spring, MD. Date of hearing: 2017-10-05. Includes bibliographical references. n-us--- United States. United States. United States. Substance Abuse and Mental Health Services Administration Rules and practice Center for Disease Control Rules and practice National Institutes of Health (U.S.) Rules and practice Opioid abuse Government policy United States Prevention Opioids Overdose Government policy United States Prevention Pain Alternative treatment United States KF26 .L27 2017q Y 4.L 11/4:S.HRG.115-636 Y 4.L 11/4:S.HRG.115-636 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. (OCoLC)1111292059 United States. Congress. Senate. https://purl.fdlp.gov/GPO/gpo123879 https://purl.fdlp.gov/GPO/gpo123879 PUCPR 190802 20191001143159.0 on1111292002 eng